Correlation Between Cullinan Oncology and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Cullinan Oncology and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Syndax Pharmaceuticals.
Diversification Opportunities for Cullinan Oncology and Syndax Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cullinan and Syndax is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Syndax Pharmaceuticals
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Syndax Pharmaceuticals. In addition to that, Cullinan Oncology is 1.1 times more volatile than Syndax Pharmaceuticals. It trades about -0.12 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.28 per unit of volatility. If you would invest 1,308 in Syndax Pharmaceuticals on November 18, 2024 and sell it today you would earn a total of 184.00 from holding Syndax Pharmaceuticals or generate 14.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Syndax Pharmaceuticals |
Cullinan Oncology and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Syndax Pharmaceuticals
The main advantage of trading using opposite Cullinan Oncology and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |